Log in to save to my catalogue

Bucillamine-Induced Membranous Nephropathy with Crescent Formation in a Patient with Rheumatoid Arth...

Bucillamine-Induced Membranous Nephropathy with Crescent Formation in a Patient with Rheumatoid Arth...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_karger_primary_368826

Bucillamine-Induced Membranous Nephropathy with Crescent Formation in a Patient with Rheumatoid Arthritis: Case Report and Literature Review

About this item

Full title

Bucillamine-Induced Membranous Nephropathy with Crescent Formation in a Patient with Rheumatoid Arthritis: Case Report and Literature Review

Publisher

Basel, Switzerland: S. Karger AG

Journal title

Case Reports in Nephrology and Dialysis, 2015-01, Vol.5 (1), p.30-38

Language

English

Formats

Publication information

Publisher

Basel, Switzerland: S. Karger AG

More information

Scope and Contents

Contents

Bucillamine is a disease-modifying antirheumatic drug that is structurally similar to D -penicillamine. The major renal side effect of bucillamine and D -penicillamine is proteinuria caused by membranous nephropathy (MN). In addition to MN, combined crescent formation has been occasionally reported in D -penicillamine-induced MN, while crescent for...

Alternative Titles

Full title

Bucillamine-Induced Membranous Nephropathy with Crescent Formation in a Patient with Rheumatoid Arthritis: Case Report and Literature Review

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_karger_primary_368826

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_karger_primary_368826

Other Identifiers

ISSN

2296-9705

E-ISSN

2296-9705

DOI

10.1159/000368826

How to access this item